SCHEMBL4357799

SCHEMBL4357799

CCOC(OCC)[SiH2]CCCBr

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29245543 0.91
SCHEMBL704023 0.85 THRB (0.38) THRBLMNA
SCHEMBL646412 0.85 THRB (0.38) THRBLMNA
SCHEMBL6007776 0.83 THRB (0.36) THRBLMNA
SCHEMBL3104636 0.83 THRB (0.36) THRBLMNA
SCHEMBL478006 0.83 THRB (0.36) THRBLMNA
SCHEMBL27491447 0.81 THRB (0.35) THRBLMNA
SCHEMBL3595185 0.80 THRB (0.31) THRB
SCHEMBL331066 0.80 THRB (0.42) THRBLMNA
SCHEMBL15157921 0.79 THRB (0.33) THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736375-A Double-end functional solution polymerized styrene-butadiene rubber as well as preparation method and application thereof 中国石油化工股份有限公司 2024-03-22 CN claimed
CN-117736375-A Double-end functional solution polymerized styrene-butadiene rubber as well as preparation method and application thereof 中国石油化工股份有限公司 2024-03-22 CN disclosed
US-20230399346-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING ORGANOSILICON COMPOUND, AND COMPOSITION CONTAINING ORGANOSILICON COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-12-14 US disclosed
EP-4245761-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING ORGANOSILICON COMPOUND, AND COMPOSITION CONTAINING ORGANOSILICON COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-20 EP disclosed
CN-116438186-A Method for producing composition containing organosilicon compound and composition containing organosilicon compound 信越化学工业株式会社 2023-07-14 CN disclosed
WO-2022102445-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING ORGANOSILICON COMPOUND, AND COMPOSITION CONTAINING ORGANOSILICON COMPOUND 信越化学工業株式会社 2022-05-19 WO disclosed
US-7619108-B2 Process for preparing unsaturated organosilicon compounds WACKER CHEMIE AG (DE) 2009-11-17 US disclosed
US-20080293958-A1 Process for Preparing Unsaturated Organosilicon Compounds WACKER CHEMIE AG (DE) 2008-11-27 US disclosed
US-6815554-B2 REACTING A HALOALKYLSILANE WITH A SALT OF AN UNSATURATED CARBOXYLIC ACID IN THE PRESENCE OF A PHASE TRANSFER CATALYST; BONDING AGENTS WACKER-CHEMIE GMBH (DE) 2004-11-09 US disclosed
US-20020151736-A1 PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS WACKER-CHEMIE GMBH (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399346-A1 METHOD FOR PRODUCING COMPOSITION CONTAINING ORGANOSILICON COMPOUND, AND COMPOSITION CONTAINING ORGANOSILICON COMPOUND C5, C9, CA6 THRB 4627/4885LMNA 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.